Tag: Pharmaceutical Industry

Heather Bresch, chief executive officer of Mylan NV, holds up Mylan EpiPen medication during a House Oversight and Government Reform Committee hearing on Sept. 21, 2016. Lawmakers questioned Bresch about why the company raised the price of the life-saving injection to $600 for a two-pack, from $57 a shot when it took over sales of the product in 2007. (Andrew Harrer/Bloomberg)

Maryland ‘price gouging’ law meets immediate legal challenge

Kimberly Leonard · July 17, 2017 4:01 am

The problem here is very clear: How can public policy lower the price of prescription drugs? The answer, however, differs greatly depending on who you ask. (iStock photo)

Beltway Confidential

Letting the government ‘negotiate’ with drug companies is just window dressing for price controls

Brandon Arnold · July 13, 2017 4:22 pm

Lawmakers passed a bill that would let the FDA continue to collect user fees from drug and device makers, with the agency using that revenue to speed up approval of new products. (AP Photo/Andrew Harnik)

House advances FDA funding bill

Robert King · July 12, 2017 6:40 pm

Republicans are working to speed up approval of generic drugs in particular to offer more competition and lower prices.

Democrats disappointed Trump hasn’t worked to lower drug prices

Robert King · June 26, 2017 4:01 am

It's no surprise that marketing works. (AP Photo/Sue Ogrocki, File)

Are Big Pharma gifts to physicians an expensive problem, or a red herring?

Brian Joondeph · June 23, 2017 12:00 pm

Rep. Elijah Cummings, D-Md., and Rep. Peter Welch, D-Vt., who met with President Trump earlier this year over tackling drug prices, are dismayed at the lack of action from the White House. (AP Photo/Pablo Martinez Monsivais)

House Democrats slam Trump ‘betrayal’ on drug prices

Robert King · June 21, 2017 3:00 pm

This is the first time the FDA has taken steps to take a prescription painkiller off the market because of its risk for addiction. (AP Photo/Chris Post)

An FDA first: Agency asks drug company to take its opioid off the market

Kimberly Leonard · June 8, 2017 9:34 pm

One of the moves Congress and the FDA are looking at is a loophole that major pharmaceutical companies use to stop generic makers from creating a cheaper copy.

FDA takes bigger role in lowering drug prices

Robert King · June 5, 2017 4:01 am

The pharmaceutical giant has raised prices an average of 20 percent this year. (AP Photo/Richard Drew, File)

Pfizer hikes price on nearly 100 drugs, report says

Robert King · June 2, 2017 7:57 pm

Representatives of drugmaker Mylan, which produces the allergy drug EpiPen, wants to meet with Sen. Chuck Grassley to discuss a subpoena threat over documents pertaining to Medicaid's rebate program. (AP Photo/Rich Pedroncelli, File)

EpiPen maker seeks meeting with Chuck Grassley over subpoena threat, report says

Robert King · June 2, 2017 2:31 pm

In the last several years, stories of collusion, price gouging and cover-ups by industry executives have continued to unfold -- all designed to improve their bottom line at the expense of patients. (AP Photo/Mel Evans)

Beltway Confidential

4 ways Congress can put the brakes on rising pharmaceutical drug costs

Kevin Campbell · June 1, 2017 4:17 pm

The HHS inspector general's office found that the government overpaid about $1.27 billion for the allergy antidote under the Medicaid rebate program. (AP Photo/Rich Pedroncelli, File)

Grassley: Mylan fleeced taxpayers $1.27 billion for EpiPen

Robert King · May 31, 2017 7:38 pm